remdesivir
Selected indexed studies
- Remdesivir. (Profiles Drug Subst Excip Relat Methodol, 2023) [PMID:37061276]
- Remdesivir-Induced Bradycardia. (South Med J, 2023) [PMID:36863055]
- Remdesivir: First Approval. (Drugs, 2020) [PMID:32870481]
_Worker-drafted node — pending editorial review._
Connections
remdesivir is a side effect of
Sources
- Remdesivir. (2023) pubmed
- Remdesivir-Induced Bradycardia. (2023) pubmed
- Remdesivir: First Approval. (2020) pubmed
- Remdesivir: A Review in COVID-19. (2023) pubmed
- Remdesivir for the treatment of COVID-19. (2023) pubmed
- Remdesivir: From Ebola to COVID-19. (2021) pubmed
- Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics. (2022) pubmed
- Remdesivir-COVID-19: drug interactions in dentistry. (2020) pubmed
- Remdesivir for the treatment of COVID-19. (2021) pubmed
- Remdesivir: treatment of COVID-19 in special populations. (2024) pubmed